Nasal Spray Delivers New Type Of Depression Treatment, University of Toronto Study

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A nasal spray that delivers a peptide to treat depression holds promise as a potential alternative therapeutic approach, research from the Centre for Addiction and Mental Health (CAMH) shows. The study, led by CAMH’s Dr. Fang Liu, is published online in Neuropsychopharmacology.

Hey, check out all the engineering jobs. Post your resume today!